Dr. Benjamin Van Tassell, PharmD
Claim this profileVirginia Commonwealth University
Studies Heart Failure
Studies Gastrointestinal Ischemia and Infarction
3 reported clinical trials
2 drugs studied
Affiliated Hospitals
Clinical Trials Benjamin Van Tassell, PharmD is currently running
Anakinra
for Heart Attack Prevention of Heart Failure
Patients who have a heart attack are at high risk for future development of heart failure ('weakening of the heart'). The researchers believe that the reaction of the heart muscle to injury (inflammation) during a heart attack may be contributing to the risk of heart failure. The current study will test the ability of an anti-inflammatory medicine (anakinra) to block the inflammation in the body during and after a heart attack.
Recruiting0 awards Phase 24 criteria
Anakinra
for Heart Failure
End-stage heart failure (HF) is a progressive illness with a mortality rate similar to most advanced cancers.Roughly 5% of patients with HF have end-stage disease that is refractory to medical therapy (stage D heart failure). When patients reach this point in their disease, the only treatments known to prolong life are cardiac transplantation or left ventricular assist devices. In patients who do not qualify for these options, or elect a palliative approach, inotropes are frequently used to improve hemodynamics through an increase in cardiac output and reduction in filling pressures. While inotropes provide profound symptomatic relief, these benefits are accompanied by significant risks of progressive adverse cardiac remodeling, arrhythmias, and sudden death. There is, therefore, an urgent need to develop strategies to reduce the dose or duration of inotrope use in the management of patients with stage D of HF.
Recruiting1 award Phase 16 criteria
More about Benjamin Van Tassell, PharmD
Clinical Trial Related2 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Benjamin Van Tassell, PharmD has experience with
- Anakinra
- Placebo
Breakdown of trials Benjamin Van Tassell, PharmD has run
Heart Failure
Gastrointestinal Ischemia and Infarction
Allergic Reaction
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Benjamin Van Tassell, PharmD specialize in?
Benjamin Van Tassell, PharmD focuses on Heart Failure and Gastrointestinal Ischemia and Infarction. In particular, much of their work with Heart Failure has involved treating patients, or patients who are undergoing treatment.
Is Benjamin Van Tassell, PharmD currently recruiting for clinical trials?
Yes, Benjamin Van Tassell, PharmD is currently recruiting for 2 clinical trials in Richmond Virginia. If you're interested in participating, you should apply.
Are there any treatments that Benjamin Van Tassell, PharmD has studied deeply?
Yes, Benjamin Van Tassell, PharmD has studied treatments such as Anakinra, Placebo.
What is the best way to schedule an appointment with Benjamin Van Tassell, PharmD?
Apply for one of the trials that Benjamin Van Tassell, PharmD is conducting.
What is the office address of Benjamin Van Tassell, PharmD?
The office of Benjamin Van Tassell, PharmD is located at: Virginia Commonwealth University, Richmond, Virginia 23284 United States. This is the address for their practice at the Virginia Commonwealth University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.